The objective of this IAA is to develop critical reagents (to include inactivated antigenic materials, nucleic acids and antibodies) for use in basic research and product development activities for Category A-C pathogens.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2015
Total Cost
Indirect Cost
City
State
Country
Zip Code